Listed

iBio, Inc.

IBIONasdaqCIK 1420720HealthcareFiscal year ends Jun 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2026
Operating income−$11.4m, Q4 FY2026
Net income−$10.6m, Q4 FY2026
iBio, Inc., income statement, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Revenue$m0.1Revenue, Q1 FY2024, three months to 2023-09-30$50.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure0.0Revenue, Q2 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-02-10, accession 0001420720-25-000012. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-02, accession 0001420720-25-000025. Derived: 9-month figure less the 6-month figure.Report this figure0.2Revenue, Q4 FY2024, three months to 2024-06-30$175.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-09-05, accession 0001558370-25-011888. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure0.2Revenue, Q2 FY2025, three months to 2024-12-31$200.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure0.2Revenue, Q4 FY2025, three months to 2025-06-30$200.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2026, three months to 2025-09-30$100.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure0.0Revenue, Q2 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure0.0Revenue, Q3 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001104659-26-059416. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m1.6Research and development, Q1 FY2024, three months to 2023-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure1.5Research and development, Q2 FY2024, three months to 2023-12-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure0.9Research and development, Q3 FY2024, three months to 2024-03-31$904.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure1.1Research and development, Q4 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-09-05, accession 0001558370-25-011888. Derived: 12-month figure less the 9-month figure.Report this figure1.3Research and development, Q1 FY2025, three months to 2024-09-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure1.9Research and development, Q2 FY2025, three months to 2024-12-31$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure1.9Research and development, Q3 FY2025, three months to 2025-03-31$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure3.2Research and development, Q4 FY2025, three months to 2025-06-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure3.6Research and development, Q1 FY2026, three months to 2025-09-30$3.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure4.3Research and development, Q2 FY2026, three months to 2025-12-31$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure3.3Research and development, Q3 FY2026, three months to 2026-03-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure8.6Research and development, Q4 FY2026, three months to 2026-06-30$8.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure
Operating income$m(5.1)Operating income, Q1 FY2024, three months to 2023-09-30−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure(4.5)Operating income, Q2 FY2024, three months to 2023-12-31−$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure(3.6)Operating income, Q3 FY2024, three months to 2024-03-31−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure(3.4)Operating income, Q4 FY2024, three months to 2024-06-30−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-09-05, accession 0001558370-25-011888. Derived: 12-month figure less the 9-month figure.Report this figure(4.1)Operating income, Q1 FY2025, three months to 2024-09-30−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure(4.4)Operating income, Q2 FY2025, three months to 2024-12-31−$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure(4.9)Operating income, Q3 FY2025, three months to 2025-03-31−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure(5.2)Operating income, Q4 FY2025, three months to 2025-06-30−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(6.0)Operating income, Q1 FY2026, three months to 2025-09-30−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure(9.4)Operating income, Q2 FY2026, three months to 2025-12-31−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure(8.4)Operating income, Q3 FY2026, three months to 2026-03-31−$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure(11.4)Operating income, Q4 FY2026, three months to 2026-06-30−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure
Interest expense$m0.0Interest expense, Q1 FY2024, three months to 2023-09-30$26.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001558370-23-019043.Report this figure0.0Interest expense, Q2 FY2024, three months to 2023-12-31$34.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-02-09, accession 0001558370-24-000934.Report this figure0.1Interest expense, Q3 FY2024, three months to 2024-03-31$52.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-13, accession 0001420720-24-000020.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-06-30$60.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-09-05, accession 0001558370-25-011888. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2025, three months to 2024-09-30$57.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure0.1Interest expense, Q2 FY2025, three months to 2024-12-31$57.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure0.1Interest expense, Q3 FY2025, three months to 2025-03-31$54.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-06-30$44.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2025-09-30$36.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure0.0Interest expense, Q2 FY2026, three months to 2025-12-31$41.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure0.0Interest expense, Q3 FY2026, three months to 2026-03-31$22.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure(0.0)Interest expense, Q4 FY2026, three months to 2026-06-30−$46.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure
Income tax$m0.0Income tax, Q1 FY2024, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure0.0Income tax, Q2 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-02-09, accession 0001558370-24-000934.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-09-05, accession 0001558370-25-011888. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure0.0Income tax, Q2 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure0.0Income tax, Q2 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure0.0Income tax, Q3 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure0.0Income tax, Q4 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure
Net income$m(5.7)Net income, Q1 FY2024, three months to 2023-09-30−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure(8.2)Net income, Q2 FY2024, three months to 2023-12-31−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure(3.2)Net income, Q3 FY2024, three months to 2024-03-31−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure(7.8)Net income, Q4 FY2024, three months to 2024-06-30−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-09-05, accession 0001558370-25-011888. Derived: 12-month figure less the 9-month figure.Report this figure(4.0)Net income, Q1 FY2025, three months to 2024-09-30−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure(4.4)Net income, Q2 FY2025, three months to 2024-12-31−$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure(4.9)Net income, Q3 FY2025, three months to 2025-03-31−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure(5.2)Net income, Q4 FY2025, three months to 2025-06-30−$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(5.7)Net income, Q1 FY2026, three months to 2025-09-30−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure(9.0)Net income, Q2 FY2026, three months to 2025-12-31−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure(7.7)Net income, Q3 FY2026, three months to 2026-03-31−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure(10.6)Net income, Q4 FY2026, three months to 2026-06-30−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(4.80)Diluted EPS, Q1 FY2024, three months to 2023-09-30−$4.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure(4.42)Diluted EPS, Q2 FY2024, three months to 2023-12-31−$4.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure(0.85)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figurenot reported(0.46)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure(0.48)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure(0.49)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figurenot reported(0.11)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure(0.09)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure(0.06)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figurenot reported
Basic EPS$ per share(4.80)Basic EPS, Q1 FY2024, three months to 2023-09-30−$4.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure(4.42)Basic EPS, Q2 FY2024, three months to 2023-12-31−$4.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure(0.85)Basic EPS, Q3 FY2024, three months to 2024-03-31−$0.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figurenot reported(0.46)Basic EPS, Q1 FY2025, three months to 2024-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure(0.48)Basic EPS, Q2 FY2025, three months to 2024-12-31−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure(0.49)Basic EPS, Q3 FY2025, three months to 2025-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figurenot reported(0.11)Basic EPS, Q1 FY2026, three months to 2025-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure(0.09)Basic EPS, Q2 FY2026, three months to 2025-12-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure(0.06)Basic EPS, Q3 FY2026, three months to 2026-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figurenot reported

Balance sheet

Cash and equivalents$56.4m, FY2026
Shareholders' equity$85.7m, FY2026
iBio, Inc., balance sheet, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31FY20262026-06-30
Cash and equivalents$m1.5Cash and equivalents, Q1 FY2024, at 2023-09-30$1.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001558370-23-019043.Report this figure2.8Cash and equivalents, Q2 FY2024, at 2023-12-31$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-09, accession 0001558370-24-000934.Report this figure5.3Cash and equivalents, Q3 FY2024, at 2024-03-31$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001420720-24-000020.Report this figure14.2Cash and equivalents, FY2024, at 2024-06-30$14.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-09-05, accession 0001558370-25-011888.Report this figure11.0Cash and equivalents, Q1 FY2025, at 2024-09-30$11.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure7.0Cash and equivalents, Q2 FY2025, at 2024-12-31$7.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure5.0Cash and equivalents, Q3 FY2025, at 2025-03-31$5.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure8.6Cash and equivalents, FY2025, at 2025-06-30$8.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure28.1Cash and equivalents, Q1 FY2026, at 2025-09-30$28.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure28.7Cash and equivalents, Q2 FY2026, at 2025-12-31$28.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure47.6Cash and equivalents, Q3 FY2026, at 2026-03-31$47.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure56.4Cash and equivalents, FY2026, at 2026-06-30$56.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure
Current assets$m23.0Current assets, Q1 FY2024, at 2023-09-30$23.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019043.Report this figure19.7Current assets, Q2 FY2024, at 2023-12-31$19.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-09, accession 0001558370-24-000934.Report this figure36.1Current assets, Q3 FY2024, at 2024-03-31$36.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001420720-24-000020.Report this figure15.7Current assets, FY2024, at 2024-06-30$15.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-09-05, accession 0001558370-25-011888.Report this figure11.7Current assets, Q1 FY2025, at 2024-09-30$11.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure8.3Current assets, Q2 FY2025, at 2024-12-31$8.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure6.1Current assets, Q3 FY2025, at 2025-03-31$6.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure9.7Current assets, FY2025, at 2025-06-30$9.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure50.8Current assets, Q1 FY2026, at 2025-09-30$50.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure53.4Current assets, Q2 FY2026, at 2025-12-31$53.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure77.3Current assets, Q3 FY2026, at 2026-03-31$77.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure92.2Current assets, FY2026, at 2026-06-30$92.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure
Total assets$m37.7Total assets, Q1 FY2024, at 2023-09-30$37.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001558370-23-019043.Report this figure34.0Total assets, Q2 FY2024, at 2023-12-31$34.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-09, accession 0001558370-24-000934.Report this figure50.2Total assets, Q3 FY2024, at 2024-03-31$50.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001420720-24-000020.Report this figure28.7Total assets, FY2024, at 2024-06-30$28.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-09-05, accession 0001558370-25-011888.Report this figure24.5Total assets, Q1 FY2025, at 2024-09-30$24.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure21.7Total assets, Q2 FY2025, at 2024-12-31$21.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure19.1Total assets, Q3 FY2025, at 2025-03-31$19.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure23.2Total assets, FY2025, at 2025-06-30$23.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure64.2Total assets, Q1 FY2026, at 2025-09-30$64.2m. XBRL concept us-gaap:Assets. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure64.4Total assets, Q2 FY2026, at 2025-12-31$64.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure85.8Total assets, Q3 FY2026, at 2026-03-31$85.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure99.1Total assets, FY2026, at 2026-06-30$99.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure
Current liabilities$m20.7Current liabilities, Q1 FY2024, at 2023-09-30$20.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019043.Report this figure21.6Current liabilities, Q2 FY2024, at 2023-12-31$21.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-09, accession 0001558370-24-000934.Report this figure21.4Current liabilities, Q3 FY2024, at 2024-03-31$21.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001420720-24-000020.Report this figure3.8Current liabilities, FY2024, at 2024-06-30$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-09-05, accession 0001558370-25-011888.Report this figure3.5Current liabilities, Q1 FY2025, at 2024-09-30$3.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure4.7Current liabilities, Q2 FY2025, at 2024-12-31$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure5.4Current liabilities, Q3 FY2025, at 2025-03-31$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure6.1Current liabilities, FY2025, at 2025-06-30$6.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure6.0Current liabilities, Q1 FY2026, at 2025-09-30$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure5.9Current liabilities, Q2 FY2026, at 2025-12-31$5.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure6.5Current liabilities, Q3 FY2026, at 2026-03-31$6.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure11.7Current liabilities, FY2026, at 2026-06-30$11.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure
Total liabilities$m24.5Total liabilities, Q1 FY2024, at 2023-09-30$24.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001558370-23-019043.Report this figure24.8Total liabilities, Q2 FY2024, at 2023-12-31$24.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-09, accession 0001558370-24-000934.Report this figure25.3Total liabilities, Q3 FY2024, at 2024-03-31$25.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001420720-24-000020.Report this figure7.4Total liabilities, FY2024, at 2024-06-30$7.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-09-05, accession 0001558370-25-011888.Report this figure6.8Total liabilities, Q1 FY2025, at 2024-09-30$6.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure7.8Total liabilities, Q2 FY2025, at 2024-12-31$7.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure7.7Total liabilities, Q3 FY2025, at 2025-03-31$7.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure8.3Total liabilities, FY2025, at 2025-06-30$8.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure8.1Total liabilities, Q1 FY2026, at 2025-09-30$8.1m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure7.8Total liabilities, Q2 FY2026, at 2025-12-31$7.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure8.3Total liabilities, Q3 FY2026, at 2026-03-31$8.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure13.4Total liabilities, FY2026, at 2026-06-30$13.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure
Shareholders' equity$m13.2Shareholders' equity, Q1 FY2024, at 2023-09-30$13.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-14, accession 0001558370-23-019043.Report this figure9.2Shareholders' equity, Q2 FY2024, at 2023-12-31$9.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-02-09, accession 0001558370-24-000934.Report this figure24.9Shareholders' equity, Q3 FY2024, at 2024-03-31$24.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-13, accession 0001420720-24-000020.Report this figure21.3Shareholders' equity, FY2024, at 2024-06-30$21.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-09-05, accession 0001558370-25-011888.Report this figure17.8Shareholders' equity, Q1 FY2025, at 2024-09-30$17.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure13.9Shareholders' equity, Q2 FY2025, at 2024-12-31$13.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure11.4Shareholders' equity, Q3 FY2025, at 2025-03-31$11.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure14.9Shareholders' equity, FY2025, at 2025-06-30$14.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure56.0Shareholders' equity, Q1 FY2026, at 2025-09-30$56.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure56.6Shareholders' equity, Q2 FY2026, at 2025-12-31$56.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure77.5Shareholders' equity, Q3 FY2026, at 2026-03-31$77.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure85.7Shareholders' equity, FY2026, at 2026-06-30$85.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure

Cash flow

Operating cash flow−$6.2m, Q4 FY2026
Capital expenditure$19.0k, Q4 FY2026
iBio, Inc., cash flow, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Operating cash flow$k(5,340)Operating cash flow, Q1 FY2024, three months to 2023-09-30−$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure(4,706)Operating cash flow, Q2 FY2024, three months to 2023-12-31−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-10, accession 0001420720-25-000012. Derived: 6-month figure less the 3-month figure.Report this figure(3,654)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-02, accession 0001420720-25-000025. Derived: 9-month figure less the 6-month figure.Report this figure(4,854)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-09-05, accession 0001558370-25-011888. Derived: 12-month figure less the 9-month figure.Report this figure(3,715)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure(3,869)Operating cash flow, Q2 FY2025, three months to 2024-12-31−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-10, accession 0001420720-26-000004. Derived: 6-month figure less the 3-month figure.Report this figure(3,105)Operating cash flow, Q3 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001104659-26-059416. Derived: 9-month figure less the 6-month figure.Report this figure(4,615)Operating cash flow, Q4 FY2025, three months to 2025-06-30−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(5,665)Operating cash flow, Q1 FY2026, three months to 2025-09-30−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure(5,241)Operating cash flow, Q2 FY2026, three months to 2025-12-31−$5.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-10, accession 0001420720-26-000004. Derived: 6-month figure less the 3-month figure.Report this figure(6,084)Operating cash flow, Q3 FY2026, three months to 2026-03-31−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001104659-26-059416. Derived: 9-month figure less the 6-month figure.Report this figure(6,228)Operating cash flow, Q4 FY2026, three months to 2026-06-30−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure
Capital expenditure$knot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-02, accession 0001420720-25-000025. Derived: 9-month figure less the 6-month figure.Report this figure210Capital expenditure, Q4 FY2024, three months to 2024-06-30$210.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-09-05, accession 0001558370-25-011888. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure1.0Capital expenditure, Q2 FY2025, three months to 2024-12-31$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-10, accession 0001420720-26-000004. Derived: 6-month figure less the 3-month figure.Report this figure14.0Capital expenditure, Q3 FY2025, three months to 2025-03-31$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001104659-26-059416. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q4 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure32.0Capital expenditure, Q1 FY2026, three months to 2025-09-30$32.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure516Capital expenditure, Q2 FY2026, three months to 2025-12-31$516.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-10, accession 0001420720-26-000004. Derived: 6-month figure less the 3-month figure.Report this figure11.0Capital expenditure, Q3 FY2026, three months to 2026-03-31$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001104659-26-059416. Derived: 9-month figure less the 6-month figure.Report this figure19.0Capital expenditure, Q4 FY2026, three months to 2026-06-30$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-28, accession 0001420720-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure

Shares

Diluted shares (weighted)119.60m, Q3 FY2026
iBio, Inc., shares, quarterly
Line itemUnitQ1 FY20232022-09-30Q2 FY20232022-12-31Q3 FY20232023-03-31Q1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31
Diluted shares (weighted)m shares8.8Diluted shares (weighted), Q1 FY2023, three months to 2022-09-308,842,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001558370-23-019043.Report this figure0.5Diluted shares (weighted), Q2 FY2023, three months to 2022-12-31490,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-09, accession 0001558370-24-000934.Report this figure0.7Diluted shares (weighted), Q3 FY2023, three months to 2023-03-31659,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001420720-24-000020.Report this figure1.2Diluted shares (weighted), Q1 FY2024, three months to 2023-09-301,198,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001420720-24-000054.Report this figure1.9Diluted shares (weighted), Q2 FY2024, three months to 2023-12-311,856,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-10, accession 0001420720-25-000012.Report this figure3.7Diluted shares (weighted), Q3 FY2024, three months to 2024-03-313,713,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-02, accession 0001420720-25-000025.Report this figure8.6Diluted shares (weighted), Q1 FY2025, three months to 2024-09-308,633,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure9.1Diluted shares (weighted), Q2 FY2025, three months to 2024-12-319,132,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure9.9Diluted shares (weighted), Q3 FY2025, three months to 2025-03-319,862,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure53.0Diluted shares (weighted), Q1 FY2026, three months to 2025-09-3052,981,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2025-11-17, accession 0001420720-25-000043.Report this figure99.1Diluted shares (weighted), Q2 FY2026, three months to 2025-12-3199,133,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-10, accession 0001420720-26-000004.Report this figure120Diluted shares (weighted), Q3 FY2026, three months to 2026-03-31119,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001104659-26-059416.Report this figure

Shares outstanding: 64.31mShares outstanding, period not labelled, at 2026-08-2764,307,256 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2026-08-28, accession 0001420720-26-000020.Report this figure at Aug 27, 2026, from the cover of the 10-K filed Aug 28, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.